Skip to main content

Table 2 Cohort results for 2014 of camp and non-camp Syrian refugee culture-confirmed patients who started anti-TB treatment 9 months prior

From: “Impact of and response to increased tuberculosis prevalence among Syrian refugees compared with Jordanian tuberculosis prevalence: case study of a tuberculosis public health strategy”

Tuberculosis cohort findings* by quarter, 2014

1st quarter % (n/N)

2nd quarter % (n/N)

3rd quarter % (n/N)

Cure/completion rate (without MDR†)

91 % (21/23)

96 % (23/24)

85 % (17/20)

Likely to complete treatment (without MDR)

91 % (21/23)

100 % (24/24)

95 % (19/20)

Death rate

0 % (0/0)

0 % (0/0)

5 % (1/20)

Default treatment rate

9 % (2/23)

0 % (0/0)

0 % (0/0)

Fail treatment rate

0 % (0/0)

0 % (0/0)

0 % (0/0)

  1. *Source definitions: CDC. Understanding the TB cohort review process: instruction guide, 2006. [http://www.cdc.gov/tb/publications/guidestoolkits/cohort/method.htm]
  2. †MDR, multiple-drug resistant